Hayato Yabe

936 total citations
51 papers, 566 citations indexed

About

Hayato Yabe is a scholar working on Neurology, Epidemiology and Rheumatology. According to data from OpenAlex, Hayato Yabe has authored 51 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 13 papers in Epidemiology and 11 papers in Rheumatology. Recurrent topics in Hayato Yabe's work include Parkinson's Disease Mechanisms and Treatments (16 papers), Neurological disorders and treatments (10 papers) and Restless Legs Syndrome Research (6 papers). Hayato Yabe is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (16 papers), Neurological disorders and treatments (10 papers) and Restless Legs Syndrome Research (6 papers). Hayato Yabe collaborates with scholars based in Japan and United States. Hayato Yabe's co-authors include Masahiro Nagai, Masahiro Nomoto, Noriko Nishikawa, Takashi Moritoyo, Rina Ando, Hirotaka Iwaki, Ryuta Kamekura, Shingo Ichimiya, Katsunori Shigehara and Madoka Kubo and has published in prestigious journals such as Brain Research, Clinical Pharmacology & Therapeutics and Journal of the Neurological Sciences.

In The Last Decade

Hayato Yabe

49 papers receiving 558 citations

Peers

Countries citing papers authored by Hayato Yabe

Since Specialization

Citations

This map shows the geographic impact of Hayato Yabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hayato Yabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hayato Yabe more than expected).

Fields of papers citing papers by Hayato Yabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hayato Yabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hayato Yabe. The network helps show where Hayato Yabe may publish in the future.

Co-authorship network of co-authors of Hayato Yabe

This figure shows the co-authorship network connecting the top 25 collaborators of Hayato Yabe. A scholar is included among the top collaborators of Hayato Yabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hayato Yabe. Hayato Yabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimization of oral entacapone administration in patients undergoing levodopa–carbidopa intestinal gel treatment 2024 ·Journal of the Neurological Sciences ·(unknown), Yuko Ito, Yuki Yamanishi, Satoshi Tada, Rina Ando, Hayato Yabe, Masahiro Nagai	1
2	Concomitant use of magnesium oxide significantly decreases absorption of levodopa preparations in patients with Parkinson’s disease 2023 ·Clinical Parkinsonism & Related Disorders ·(unknown), Hayato Yabe, Masahiro Nagai	3
3	Pseudo-outbreak of Mycobacterium lentiflavum at a general hospital in Japan 2023 ·Infection Control and Hospital Epidemiology ·(unknown), Koji Kuronuma, Yasuo Kitamura, (unknown), Hayato Yabe, (unknown), Toyotaka Sato, (unknown), (unknown), Motohiro Horiuchi, Shin‐ichi Yokota, Yoshihiro Fujiya, Atsushi Saito, Satoshi Takahashi, Hirofumi Chiba	1
4	Serum GDF-15 Levels in Patients with Parkinson’s Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy 2023 ·Neurology International ·(unknown), Hayato Yabe, Masahiro Nagai	1
5	Fasting state is one of the factors associated with plasma levodopa fluctuations during levodopa‒carbidopa intestinal gel treatment 2021 ·Parkinsonism & Related Disorders ·(unknown), Yuko Hosokawa, Akira Yoshida, Yuki Yamanishi, Satoshi Tada, Rina Ando, Hayato Yabe, Masahiro Nagai	6
6	Serum growth differentiation factor 15 levels and clinical manifestations in patients with thiamine deficiency 2020 ·Neurology and Clinical Neuroscience ·(unknown), Hayato Yabe, Masahiro Nagai	3
7	Relapse of neuromyelitis optica with occipital neuralgia and elevated CSF neopterin 2020 ·Neurology and Clinical Neuroscience ·(unknown), Hayato Yabe, Yuki Yamanishi, Satoshi Tada, Rina Ando, Masahiro Nagai	2
8	Three cases of rheumatoid meningitis with elevated CSF neopterin levels 2020 ·Journal of Neuroimmunology ·(unknown), Hayato Yabe, Yuki Yamanishi, Satoshi Tada, Rina Ando, Masahiro Nagai	6
9	Abnormal upper gastrointestinal structures underlying levodopa malabsorption 2020 ·Journal of the Neurological Sciences ·(unknown), Hayato Yabe, Masahiro Nagai, Masahiro Nomoto	2
10	A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion 2019 ·Multiple Sclerosis and Related Disorders ·(unknown), Yuki Yamanishi, Satoshi Tada, Rina Ando, Hayato Yabe, Masahiro Nagai, Masahiro Nomoto	11
11	Acromioclavicular joint arthritis as the first manifestation of Austrian syndrome 2019 ·Journal of Infection and Chemotherapy ·(unknown), Yuki Yamanishi, Satoshi Tada, Rina Ando, Hayato Yabe, Masahiro Nagai	1
12	Repetitive brainstem lesions in mitochondrial DNA 11778G>A mutation of Leber hereditary optic neuropathy 2019 ·eNeurologicalSci ·(unknown), Yuki Yamanishi, Satoshi Tada, Rina Ando, Hayato Yabe, Masahiro Nagai, Masahiro Nomoto	2
13	IL-10+ T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease 2019 ·Immunology Letters ·(unknown), Ryuta Kamekura, Motohisa Yamamoto, Kenichi Takano, Hiromi Takaki, Hayato Yabe, (unknown), Katsunori Shigehara, Tetsuo Himi, Hiroki Takahashi, Shingo Ichimiya	32
14	<b>Relationship between Serious Traffic Accidents and Medications in Patients with Parkinson's Disease </b> 2017 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Rina Ando, (unknown), Hirotaka Iwaki, (unknown), Hayato Yabe, Noriko Nishikawa, Masahiro Nagai, Masahiro Nomoto	1
15	DAT SPECT may have diagnostic value in prodromal SCA2 patients with parkinsonism 2017 ·Parkinsonism & Related Disorders ·(unknown), Satoshi Tada, Rina Ando, Hirotaka Iwaki, Hayato Yabe, Noriko Nishikawa, Masahiro Nagai, Hiroshi Takashima, Masahiro Nomoto	6
16	Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia 2014 ·Haematologica ·Hiroshi Sakaguchi, Nobuhiko Nishio, Asahito Hama, Nozomu Kawashima, Xinan Wang, Atsushi Narita, Sayoko Doisaki, Yinyan Xu, Hideki Muramatsu, Nao Yoshida, Yoshiyuki Takahashi, Kazuko Kudo, Hiroshi Moritake, (unknown), Ryōji Kobayashi, Etsuro Ito, Hayato Yabe, Shouichi Ohga, Akira Ohara, S Kojima, (unknown)	33
17	Coadministration of Domperidone Increases Plasma Levodopa Concentration in Patients With Parkinson Disease 2012 ·Clinical Neuropharmacology ·Noriko Nishikawa, Masahiro Nagai, (unknown), Hirotaka Iwaki, Hayato Yabe, Masahiro Nomoto	22
18	Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group 2011 ·Haematologica ·(unknown), Etsuro Ito, Akira Ohara, Yoshiyuki Kosaka, Masahiro Tsuchida, Hiroshi Yagasaki, Hideo Mugishima, Hayato Yabe, Akira Morimoto, (unknown), Hideki Muramatsu, Asahito Hama, Takashi Kaneko, Masayuki Nagasawa, Atsushi Kikuta, Yuko Osugi, Fumio Bessho, T Nakahata, (unknown), S Kojima, (unknown)	20
19	Inter- and intra-individual variation in L-dopa pharmacokinetics in the treatment of Parkinson's disease 2009 ·Parkinsonism & Related Disorders ·Masahiro Nomoto, Noriko Nishikawa, Masahiro Nagai, Hayato Yabe, (unknown), Hiroyoko Moritoyo, Takashi Moritoyo, Madoka Kubo	10
20	Zonisamide Increases Dopamine Turnover in the Striatum of Mice and Common Marmosets Treated With MPTP 2009 ·Journal of Pharmacological Sciences ·Hayato Yabe, Mohammed E. Choudhury, Madoka Kubo, Noriko Nishikawa, Masahiro Nagai, Masahiro Nomoto	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact